FR2452481A1 - 24,24-difluoro-1a,25-dixydroxycholecalciferol et composition pharmaceutique renfermant ce produit - Google Patents
24,24-difluoro-1a,25-dixydroxycholecalciferol et composition pharmaceutique renfermant ce produitInfo
- Publication number
- FR2452481A1 FR2452481A1 FR8005935A FR8005935A FR2452481A1 FR 2452481 A1 FR2452481 A1 FR 2452481A1 FR 8005935 A FR8005935 A FR 8005935A FR 8005935 A FR8005935 A FR 8005935A FR 2452481 A1 FR2452481 A1 FR 2452481A1
- Authority
- FR
- France
- Prior art keywords
- difluoro
- calcium
- dixydroxycholecalciferol
- product
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 3
- 239000011575 calcium Substances 0.000 abstract 3
- 229910052791 calcium Inorganic materials 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 abstract 1
- GMRQFYUYWCNGIN-NKMMMXOESA-N calcitriol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C GMRQFYUYWCNGIN-NKMMMXOESA-N 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000000968 intestinal effect Effects 0.000 abstract 1
- 230000004060 metabolic process Effects 0.000 abstract 1
- 239000011574 phosphorus Substances 0.000 abstract 1
- 229910052698 phosphorus Inorganic materials 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
- 229940088594 vitamin Drugs 0.000 abstract 1
- 239000011782 vitamin Substances 0.000 abstract 1
- 229930003231 vitamin Natural products 0.000 abstract 1
- 235000013343 vitamin Nutrition 0.000 abstract 1
- 150000003710 vitamin D derivatives Chemical class 0.000 abstract 1
- 150000003722 vitamin derivatives Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C35/48—Halogenated derivatives
- C07C35/52—Alcohols with a condensed ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/14—All rings being cycloaliphatic
- C07C2602/24—All rings being cycloaliphatic the ring system containing nine carbon atoms, e.g. perhydroindane
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nutrition Science (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Character Discrimination (AREA)
- Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/024,848 US4201881A (en) | 1979-03-28 | 1979-03-28 | 24,24-Difluoro-1α,25-dihydroxycholecalciferol |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2452481A1 true FR2452481A1 (fr) | 1980-10-24 |
| FR2452481B1 FR2452481B1 (enExample) | 1984-10-19 |
Family
ID=21822707
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR8005935A Granted FR2452481A1 (fr) | 1979-03-28 | 1980-03-17 | 24,24-difluoro-1a,25-dixydroxycholecalciferol et composition pharmaceutique renfermant ce produit |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US4201881A (enExample) |
| JP (2) | JPS6342618B2 (enExample) |
| AU (1) | AU530015B2 (enExample) |
| BE (1) | BE882143A (enExample) |
| CH (1) | CH650240A5 (enExample) |
| DK (1) | DK147300C (enExample) |
| FR (1) | FR2452481A1 (enExample) |
| GB (2) | GB2045765B (enExample) |
| IE (1) | IE49753B1 (enExample) |
| IL (1) | IL58526A (enExample) |
| IT (1) | IT1140776B (enExample) |
| NL (1) | NL7920190A (enExample) |
| NZ (1) | NZ191900A (enExample) |
| SE (1) | SE8008339L (enExample) |
| WO (1) | WO1980002028A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4284577A (en) * | 1979-02-16 | 1981-08-18 | Sachiko Yamada | Novel vitamin D3 derivative and process for preparing the same |
| EP0073465B1 (de) * | 1981-08-28 | 1986-02-05 | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft | Cholecalciferolderivate |
| CA1221031A (en) * | 1982-05-17 | 1987-04-28 | Alfred Boris | Use of a cholecalciferol derivative |
| US4456689A (en) * | 1982-05-17 | 1984-06-26 | Becton Dickinson And Company | Competitive protein binding assay using an organosilane-silica gel separation medium |
| US4428946A (en) * | 1982-07-26 | 1984-01-31 | Wisconsin Alumni Research Foundation | Method of preventing milk fever in dairy cattle |
| EP0205285B1 (en) * | 1985-05-30 | 1989-08-09 | Taisho Pharmaceutical Co. Ltd | Vitamin d3 derivatives |
| WO1987003282A1 (fr) * | 1985-11-21 | 1987-06-04 | Taisho Pharmaceutical Co., Ltd. | Derive de la vitamine d3 |
| US4853378A (en) * | 1986-10-20 | 1989-08-01 | Sumitomo Chemical Company, Limited | Fluorine derivatives of vitamin D3 and process for producing the same |
| AU5185790A (en) * | 1989-02-16 | 1990-09-05 | University Of Georgia Research Foundation, Inc., The | Treatment of tibial dyschondroplasia |
| US5316770A (en) * | 1989-02-16 | 1994-05-31 | University Of Georgia Research Foundation, Inc. | Vitamin D derivative feed compositions and methods of use |
| US5366736A (en) * | 1989-02-16 | 1994-11-22 | University Of Georgia Research Foundation, Inc. | Vitamin D derivative feed compositions and methods of use |
| US5063234A (en) * | 1990-05-25 | 1991-11-05 | Eli Lilly And Company | Method of inhibiting demineralization of bone |
| US7718637B2 (en) * | 2007-12-28 | 2010-05-18 | Wisconsin Alumni Research Foundation | (20S)-23,23-difluoro-methylene-19-nor-bishomopregnacalciferol-vitamin D analogs |
| JP5504898B2 (ja) | 2010-01-08 | 2014-05-28 | セントラル硝子株式会社 | ジフルオロシクロプロパン化合物の製造方法 |
| GB202016614D0 (en) | 2020-10-20 | 2020-12-02 | King S College London | Compounds |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2327790A1 (fr) * | 1975-10-14 | 1977-05-13 | Merck & Co Inc | Derives bloques de cholecalciferol et de dihydrotachysterol3 |
| FR2453151A1 (fr) * | 1979-02-16 | 1980-10-31 | Yamada Sachiko | Derives de la vitamine d3, leur procede de preparation et leur application en therapeutique |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3741996A (en) * | 1971-12-02 | 1973-06-26 | Wisconsin Alumni Res Found | 1{60 -hydroxycholecalciferol |
| US3969700A (en) * | 1974-04-10 | 1976-07-13 | International Business Machines Corporation | Regional context maximum likelihood error correction for OCR, keyboard, and the like |
| FR2267590B1 (enExample) * | 1974-04-10 | 1977-05-20 | Ibm | |
| JPS5729745B2 (enExample) * | 1974-09-25 | 1982-06-24 | ||
| US3993675A (en) * | 1975-02-24 | 1976-11-23 | Hoffmann-La Roche Inc. | Process for the preparation of 1α,25-dihydroxycholecalciferol |
-
1979
- 1979-03-28 US US06/024,848 patent/US4201881A/en not_active Expired - Lifetime
- 1979-10-15 WO PCT/US1979/000899 patent/WO1980002028A1/en not_active Ceased
- 1979-10-15 NL NL7920190A patent/NL7920190A/nl unknown
- 1979-10-15 CH CH8817/80A patent/CH650240A5/de not_active IP Right Cessation
- 1979-10-15 JP JP55500243A patent/JPS6342618B2/ja not_active Expired
- 1979-10-22 IL IL58526A patent/IL58526A/xx unknown
-
1980
- 1980-02-08 NZ NZ191900A patent/NZ191900A/xx unknown
- 1980-02-22 AU AU55810/80A patent/AU530015B2/en not_active Ceased
- 1980-03-07 BE BE0/199728A patent/BE882143A/fr not_active IP Right Cessation
- 1980-03-11 IT IT20508/80A patent/IT1140776B/it active
- 1980-03-13 GB GB8008488A patent/GB2045765B/en not_active Expired
- 1980-03-13 GB GB8035585A patent/GB2067567B/en not_active Expired
- 1980-03-17 FR FR8005935A patent/FR2452481A1/fr active Granted
- 1980-03-26 IE IE619/80A patent/IE49753B1/en unknown
- 1980-11-27 DK DK505080A patent/DK147300C/da not_active IP Right Cessation
- 1980-11-27 SE SE8008339A patent/SE8008339L/xx unknown
-
1987
- 1987-09-16 JP JP62229955A patent/JPS63179855A/ja active Granted
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2327790A1 (fr) * | 1975-10-14 | 1977-05-13 | Merck & Co Inc | Derives bloques de cholecalciferol et de dihydrotachysterol3 |
| FR2453151A1 (fr) * | 1979-02-16 | 1980-10-31 | Yamada Sachiko | Derives de la vitamine d3, leur procede de preparation et leur application en therapeutique |
Non-Patent Citations (1)
| Title |
|---|
| EXBK/79 * |
Also Published As
| Publication number | Publication date |
|---|---|
| GB2045765A (en) | 1980-11-05 |
| CH650240A5 (de) | 1985-07-15 |
| AU530015B2 (en) | 1983-06-30 |
| GB2045765B (en) | 1983-06-15 |
| IE49753B1 (en) | 1985-12-11 |
| FR2452481B1 (enExample) | 1984-10-19 |
| BE882143A (fr) | 1980-07-01 |
| GB2067567A (en) | 1981-07-30 |
| IL58526A (en) | 1983-05-15 |
| NL7920190A (nl) | 1981-01-30 |
| IE800619L (en) | 1980-09-28 |
| WO1980002028A1 (en) | 1980-10-02 |
| SE8008339L (sv) | 1980-11-27 |
| JPS6342618B2 (enExample) | 1988-08-24 |
| IT8020508A0 (it) | 1980-03-11 |
| JPS63179855A (ja) | 1988-07-23 |
| IT1140776B (it) | 1986-10-10 |
| AU5581080A (en) | 1980-10-02 |
| DK147300C (da) | 1984-12-24 |
| IL58526A0 (en) | 1980-01-31 |
| DK505080A (da) | 1980-11-27 |
| US4201881A (en) | 1980-05-06 |
| JPS56500296A (enExample) | 1981-03-12 |
| GB2067567B (en) | 1983-03-02 |
| NZ191900A (en) | 1984-11-09 |
| DK147300B (da) | 1984-06-12 |
| JPH0146504B2 (enExample) | 1989-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2452481A1 (fr) | 24,24-difluoro-1a,25-dixydroxycholecalciferol et composition pharmaceutique renfermant ce produit | |
| FR2440371A1 (fr) | Nouveaux composes azotes heterocycliques, des compositions pharmaceutiques en contenant et des procedes pour les preparer | |
| FR2453148A1 (fr) | Nouveaux derives arylsulfinyle d'acide acetohydroxamique, leur procede de preparation et leur application en therapeutique | |
| FR2416012A1 (fr) | Derives de l'imidazole et medicament contenant ces substances | |
| TNSN97110A1 (fr) | Derives de 2-(2-oxo-ethylidene)-imidazolidine-4-one, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| FR2534922B1 (fr) | Procede de preparation de composes de cephem et nouveaux produits ainsi que les compositions pharmaceutiques les renfermant | |
| FR2562892B1 (fr) | Nouveaux dihydropyridinyldicarboxylates amides et esters, utilisation de ces composes comme medicament, compositions pharmaceutiques comprenant de tels composes et procede pour la preparation de tels composes | |
| TNSN98127A1 (fr) | Derives d'azetidinylpropylpiperidine , procede pour leur preparation et compositions pharmaceutiques les contenant. | |
| CA2176668A1 (fr) | Nouveaux composes spiro heterocycliques, leur procede de preparation et les compositions pharmaceutiques les contenant | |
| TNSN99013A1 (fr) | Derives d'acide dihydroxyhexanoique nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| IL97796A0 (en) | Pharmaceutical compositions containing n-alkylated 1,4-dihydropyridine-dicarboxylic acid esters,certain such compounds and their preparation | |
| MA21586A1 (fr) | Procede de preparition d'une nouvelle forme pharmaceutique a liberation prolongee comprenant un complexe resine principe actif. | |
| FR2424908A1 (fr) | Nouveaux analogues de prostacycline, leur procede de production et medicament les contenant | |
| FR2450814A1 (fr) | 24,24-difluoro-25-hydroxycholecalciferol et composition pharmaceutique renfermant ce produit | |
| ATE31300T1 (de) | Imidazol-2-yl-mercaptoalkansaeuren, verfahren zu deren herstellung und pharmazeutische formulierungen welche diese enthalten. | |
| FR2532849B1 (fr) | Composition pharmaceutique solide contenant des antibiotiques b-lactamiques, son procede de preparation et procede pour stabiliser une composition pharmaceutique | |
| FR2434162A1 (fr) | Nouveaux derives de 4-amino-2-piperidino-quinazoline, leur procede de production et medicament les contenant | |
| FR2446829A1 (fr) | Derives de polymethylene disubstitues en alpha, omega, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| FR2433541A1 (fr) | Nouveau procede de preparation de certains steroides | |
| BE893492A (fr) | Procede de preparation d'esters d'acides apovincaminiques, esters ainsi obtenus et compositions pharmaceutiques prepares avec ces esters | |
| ES8707111A1 (es) | Procedimiento para obtencion de un preparado farmaceutico para tratamiento terapeutico de enfermedades reumaticas. | |
| FR2377804A1 (fr) | Compositions analgesiques et anti-inflammatoires comprenant des derives de chromone | |
| FR2446831A1 (fr) | Derive oxyimino-e-homo-eburnane, procede pour le preparer et son utilisation dans une composition pharmaceutique pour la preparation de derives ester de l'acide apovincaminique | |
| FR2550537B1 (fr) | Diastereoisomeres de derives de l'acide glycyrrhetinique, composes pharmaceutiques contenant de tels produits et procede de preparation de ces produits | |
| MA21565A1 (fr) | Procede de preparation de nouveaux composes trudo-benzeniques, non ioniques iodes et de produits de contraste les contenant. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |